BridgeBio have substantially advanced this course of a novel therapy for ATTR-CM, utilizing the investigational drug. Preliminary trial results reveals significant outcomes for those affected from a debilitating illness. The emphasis represents the company’s focus to managing critical medical needs in this heart space. Attruby: BridgeBi… Read More